{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:14:44Z","timestamp":1791220484200,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-023-03096-7","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T02:02:26Z","timestamp":1676512946000},"page":"2183-2191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Glycolysis regulator PFKP induces human melanoma cell proliferation and tumor growth"],"prefix":"10.1007","volume":"25","author":[{"given":"Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-5172","authenticated-orcid":false,"given":"Xuejun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"3096_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/ITT.S134842","volume":"7","author":"B Domingues","year":"2018","unstructured":"Domingues B, Lopes JM, Soares P, P\u00f3pulo H. Melanoma treatment in review. Immunotargets Ther. 2018;7:35\u201349.","journal-title":"Immunotargets Ther"},{"issue":"7130","key":"3096_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nature05661","volume":"445","author":"V Gray-Schopfer","year":"2007","unstructured":"Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445(7130):851\u20137.","journal-title":"Nature"},{"issue":"2","key":"3096_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/10590500500234970","volume":"23","author":"WH Tolleson","year":"2005","unstructured":"Tolleson WH. Human melanocyte biology, toxicology, and pathology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2005;23(2):105\u201361.","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"issue":"23","key":"3096_CR4","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.3390\/ijms21238984","volume":"21","author":"K Eddy","year":"2020","unstructured":"Eddy K, Chen S. Overcoming immune evasion in melanoma. Int J Mol Sci. 2020;21(23):8984.","journal-title":"Int J Mol Sci"},{"key":"3096_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.abb.2014.07.023","volume":"563","author":"J Liu","year":"2014","unstructured":"Liu J, Fukunaga-Kalabis M, Li L, Herlyn M. Developmental pathways activated in melanocytes and melanoma. Arch Biochem Biophys. 2014;563:13\u201321.","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"3096_CR6","doi-asserted-by":"publisher","first-page":"1602496","DOI":"10.1002\/smll.201602496","volume":"13","author":"BP Jiang","year":"2017","unstructured":"Jiang BP, Zhang L, Guo XL, Shen XC, Wang Y, Zhu Y, et al. Poly(N-phenylglycine)-based nanoparticles as highly effective and targeted near-infrared photothermal therapy\/photodynamic therapeutic agents for malignant melanoma. Small. 2017;13(8):1602496.","journal-title":"Small"},{"issue":"1","key":"3096_CR7","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/S1470-2045(13)70333-4","volume":"15","author":"FB Bombelli","year":"2014","unstructured":"Bombelli FB, Webster CA, Moncrieff M, Sherwood V. The scope of nanoparticle therapies for future metastatic melanoma treatment. Lancet Oncol. 2014;15(1):e22-32.","journal-title":"Lancet Oncol"},{"issue":"Suppl 8","key":"3096_CR8","doi-asserted-by":"publisher","first-page":"viii10","DOI":"10.1093\/annonc\/mds257","volume":"23","author":"M Maio","year":"2012","unstructured":"Maio M. Melanoma as a model tumour for immuno-oncology. Ann Oncol. 2012;23(Suppl 8):viii10\u20134.","journal-title":"Ann Oncol"},{"issue":"4","key":"3096_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.bbamcr.2016.01.025","volume":"1863","author":"J Paluncic","year":"2016","unstructured":"Paluncic J, Kovacevic Z, Jansson PJ, Kalinowski D, Merlot AM, Huang ML, et al. Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling. Biochim Biophys Acta. 2016;1863(4):770\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"3096_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1523-1747.ep12371783","volume":"102","author":"NJ Ball","year":"1994","unstructured":"Ball NJ, Yohn JJ, Morelli JG, Norris DA, Golitz LE, Hoeffler JP. Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol. 1994;102(3):285\u201390.","journal-title":"J Invest Dermatol"},{"issue":"20","key":"3096_CR11","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135\u201347.","journal-title":"N Engl J Med"},{"issue":"7","key":"3096_CR12","first-page":"3114","volume":"9","author":"LJ van\u2019t Veer","year":"1989","unstructured":"van\u2019t Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, et al. N-ras mutations in human cutaneous melanoma from sun-exposed body sites. Mol Cell Biol. 1989;9(7):3114\u20136.","journal-title":"Mol Cell Biol"},{"issue":"6892","key":"3096_CR13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949\u201354.","journal-title":"Nature"},{"issue":"24","key":"3096_CR14","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95(24):1878\u201390.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"3096_CR15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.bbabio.2017.01.013","volume":"1858","author":"M Hosseini","year":"2017","unstructured":"Hosseini M, Kasraian Z, Rezvani HR. Energy metabolism in skin cancers: a therapeutic perspective. Biochim Biophys Acta Bioenerg. 2017;1858(8):712\u201322.","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"22","key":"3096_CR16","doi-asserted-by":"publisher","first-page":"19660","DOI":"10.1074\/jbc.M212375200","volume":"278","author":"AL Mosley","year":"2003","unstructured":"Mosley AL, Ozcan S. Glucose regulates insulin gene transcription by hyperacetylation of histone h4. J Biol Chem. 2003;278(22):19660\u20136.","journal-title":"J Biol Chem"},{"issue":"4","key":"3096_CR17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1161\/CIRCRESAHA.116.303936","volume":"116","author":"ST Keating","year":"2015","unstructured":"Keating ST, El-Osta A. Epigenetics and metabolism. Circ Res. 2015;116(4):715\u201336.","journal-title":"Circ Res"},{"key":"3096_CR18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1101\/sqb.2011.76.010868","volume":"76","author":"I Mor","year":"2011","unstructured":"Mor I, Cheung EC, Vousden KH. Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb Symp Quant Biol. 2011;76:211\u20136.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"3","key":"3096_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.yexmp.2009.01.003","volume":"86","author":"A Yalcin","year":"2009","unstructured":"Yalcin A, Telang S, Clem B, Chesney J. Regulation of glucose metabolism by 6-phosphofructo-2-kinase\/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol. 2009;86(3):174\u20139.","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"3096_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297\u2013308.","journal-title":"Cancer Cell"},{"issue":"5930","key":"3096_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"6","key":"3096_CR22","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/ol.2013.1599","volume":"6","author":"G Wang","year":"2013","unstructured":"Wang G, Xu Z, Wang C, Yao F, Li J, Chen C, et al. Differential phosphofructokinase-1 isoenzyme patterns associated with glycolytic efficiency in human breast cancer and paracancer tissues. Oncol Lett. 2013;6(6):1701\u20136.","journal-title":"Oncol Lett"},{"issue":"1","key":"3096_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41467-017-00906-9","volume":"8","author":"JH Lee","year":"2017","unstructured":"Lee JH, Liu R, Li J, Zhang C, Wang Y, Cai Q, et al. Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. Nat Commun. 2017;8(1):949.","journal-title":"Nat Commun"},{"issue":"19","key":"3096_CR24","doi-asserted-by":"publisher","first-page":"27142","DOI":"10.18632\/oncotarget.8382","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang J, Zhang P, Zhong J, Tan M, Ge J, Tao L, et al. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma. Oncotarget. 2016;7(19):27142\u201357.","journal-title":"Oncotarget"},{"issue":"12","key":"3096_CR25","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2174\/1871520619666190626120359","volume":"19","author":"L Cheng","year":"2019","unstructured":"Cheng L, Qin T, Ma J, Duan W, Xu Q, Li X, et al. Hypoxia-inducible factor-1\u03b1 mediates hyperglycemia-induced pancreatic cancer glycolysis. Anticancer Agents Med Chem. 2019;19(12):1503\u201312.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"3096_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.yexcr.2018.06.007","volume":"370","author":"G Chen","year":"2018","unstructured":"Chen G, Liu H, Zhang Y, Liang J, Zhu Y, Zhang M, et al. Silencing PFKP inhibits starvation-induced autophagy, glycolysis, and epithelial mesenchymal transition in oral squamous cell carcinoma. Exp Cell Res. 2018;370(1):46\u201357.","journal-title":"Exp Cell Res"},{"key":"3096_CR27","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fonc.2020.00722","volume":"10","author":"A Avagliano","year":"2020","unstructured":"Avagliano A, Fiume G, Pelagalli A, Sanit\u00e0 G, Ruocco MR, Montagnani S, et al. Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol. 2020;10:722.","journal-title":"Front Oncol"},{"issue":"1","key":"3096_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112282","volume":"396","author":"SM Umar","year":"2020","unstructured":"Umar SM, Kashyap A, Kahol S, Mathur SR, Gogia A, Deo SVS, et al. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer. Exp Cell Res. 2020;396(1): 112282.","journal-title":"Exp Cell Res"},{"key":"3096_CR29","doi-asserted-by":"publisher","first-page":"14374","DOI":"10.1038\/ncomms14374","volume":"8","author":"NH Kim","year":"2017","unstructured":"Kim NH, Cha YH, Lee J, Lee SH, Yang JH, Yun JS, et al. Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat Commun. 2017;8:14374.","journal-title":"Nat Commun"},{"issue":"10","key":"3096_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41419-018-1015-x","volume":"9","author":"K Zhou","year":"2018","unstructured":"Zhou K, Yao YL, He ZC, Chen C, Zhang XN, Yang KD, et al. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells. Cell Death Dis. 2018;9(10):988.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3096_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233750","volume":"15","author":"D Yeerken","year":"2020","unstructured":"Yeerken D, Hong R, Wang Y, Gong Y, Liu R, Yang D, et al. PFKP is transcriptionally repressed by BRCA1\/ZBRK1 and predicts prognosis in breast cancer. PLoS ONE. 2020;15(5): e0233750.","journal-title":"PLoS ONE"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-023-03096-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-023-03096-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T14:19:39Z","timestamp":1686233979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-023-03096-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["3096"],"URL":"https:\/\/doi.org\/10.1007\/s12094-023-03096-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"29 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by Ethical Committee of ZhongShan Hospital, FuDan University and conducted in accordance with the ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}